Journal of Geriatric Oncology - Volume 7/6 - Supplement 1

xxvi

Contents

UPDATES IN SURGERY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S17

SPECIAL CONSIDERATIONS WITH REGARD TO COLORECTAL SURGERY IN THE ELDERLY . . . . . . . . . . . . . . . . . .S17

WHO IS FIT FOR HAEMATOLOGICAL STEM CELL TRANSPLANTATION? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S18

HEALTH ECONOMICS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S18

CANCER TREATMENT SYSTEM IN JAPAN AND THE BEGINNING OF PRACTICE IN GERIATRIC ONCOLOGY . . . .S19

GYNAECOLOGICAL CANCERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S19

MINIMIZING PERIOPERATIVE ADVERSE EVENTS IN THE ELDERLY. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S19

IMPROVING NUTRITION STATUS SOONER RATHER THAN LATER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S20

ARE TOOLS THE RIGHT WAY TO ASSESS QUALITY OF LIFE IN ELDERLY? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S20

MULTIPLE MYELOMA IN THE ELDERLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S20

TELEHEALTH – RECENT EXPERIENCES IN ONCOLOGY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S20

SIOG 2016 – Abstract Submission – Oral Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S23

RELEVANCE OF GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH COLORECTAL CANCER . . . . . . . . . . . . . .S23

NATIONAL PATTERNS OF CARE AND OUTCOMES OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS

IN PATIENTS OVER 70. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S23

GERIATRIC ASSESSMENT AND OUTCOMES WITH CARBOPLATIN AND WEEKLY LOW-DOSE PACLITAXEL

IN ELDERLY WOMEN WITH OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCER: A

GYNECOLOGIC ONCOLOGY GROUP STUDY (GOG273). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S24

TAXANE-BASED ADJUVANT TREATMENT IN ELDERLY WOMEN WITH BREAST CANCER. A POOLED

ANALYSIS OF 5 RANDOMIZED TRIALS FROM THE HELLENIC ONCOLOGY RESEARCH GROUP . . . . . . . . . . . .S25

TRANSCRIPTION FACTORS AND CHECKPOINT INHIBITOR EXPRESSION WITH AGE: NEW MARKERS OF

IMMUNOSENESCENCE? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S25

OFATUMUMAB AS FRONT-LINE TREATMENT FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

THAT ARE ELDERLY AND HAVE SEVERE CO-MORBIDITIES AND/OR OTHER MALIGNANCIES . . . . . . . . . . . . .S26

WHAT EVIDENCE DO WE HAVE FOR TREATING RELAPSED/REFRACTORY AML IN PATIENTS 70 AND

OLDER? A SYSTEMATIC REVIEW OF THE LITERATURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S27

EARLY CASE MANAGEMENT IN THE OLDER FRENCH HEMATOLOGICAL MALIGNANCIES PATIENT

RECEIVING CHEMOTHERAPY, PRELEMINARY RESULTS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S27

DEPRESSION IS ASSOCIATEDWITH SLEEP DISTURBANCE IN OLDER ADULTS WITH CANCER . . . . . . . . . . . . . .S28

A PHASE II RCT OF THREE EXERCISE DELIVERY METHODS IN OLDER MENWITH PROSTATE CANCER ON

ANDROGEN DEPRIVATION THERAPY. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S28

PREVALENCE AND FACTORS ASSOCIATED WITH HIGH LEVEL OF DISTRESS AMONG OLDER CANCER

PATIENTS UNDERGOING SURGERY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S29

CHOOSING TO TRUST: CANCER TREATMENT DECISION MAKING FROM THE PERSPECTIVE OF OLDER

ADULTS WITH COLORECTAL CANCER. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S30

LONG TERM OUTCOME IN ELDERLY SURGICAL CANCER PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S30

INCLUSION OF ELDERLY PATIENTS IN ONCOLOGY CLINICAL TRIALS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S31

LARGE OUTCOME DISPARITIES BY OLDER AGE AND 21-GENE RECURRENCE SCORE (RS) RESULT IN

HORMONE RECEPTOR POSITIVE (HR+) BREAST CANCER (BC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S31

PRIMARY ENDPOINTS TO ASSESS TREATMENT EFFICACY IN CLINICAL TRIALS CONDUCTED IN ELDERLY

CANCER PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S32

FRAILTY AND SYSTEMIC INFLAMMATION-BASED GLASGOW PROGNOSTIC SCORE . . . . . . . . . . . . . . . . . . . . . .S33

A CLINICAL SCORE TO PREDICT THE EARLY DEATH AT 100 DAYS AFTER A COMPREHENSIVE GERIATRIC

ASSESSMENT (CGA) IN ELDERLY METASTATIC CANCERS, ANALYSIS FROM A PROSPECTIVE COHORT

STUDYWITH 1048 PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S34

AN OBSERVATIONAL STUDY OF THE INTERVENTIONS PROVIDED BY A MULTIDISCIPLINARY TEAM

PROVIDING COMPREHENSIVE GERIATRIC ASSESSMENT TO OLDER ADULTS WITH UPPER GASTRO-

INTESTINAL CANCERS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S34

A FEASIBILITY TRIAL OF GERIATRIC ASSESSMENT AND INTEGRATED CARE PLAN FOR OLDER CANCER

PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S35

SIOG 2016 – Abstract Submission – Poster presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S37

RETROSPECTIVE STUDY EVALUATING THE EFFICACY AND SAFETY OF FULVESTRANT AS FIRST OR

SECOND LINE TREATMENT OF METASTATIC BREAST CANCER PATIENTS OVER 70 YEARS OF AGE . . . . . . . .S37

PRACTICE MANAGEMENT FOR ELDERLY PATIENTS WITH BREAST CANCER FROM IMPLICATIONS OF A

SURVEY BY THE JAPAN CLINICAL ONCOLOGY GROUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S37

SERUMMETABOLOMIC PROFILES FOR DISCRIMINATING EARLY FROMMETASTATIC DISEASE IN ELDERLY

PATIENTS WITH COLORECTAL CANCER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S38

OUTCOMES OF HYPO FRACTIONATED RADICAL RADIOTHERAPY IN PATIENTS WITH NON SMALL CELL

LUNG CANCER (NSCLC) OVER THE AGE OF 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S38

THE BENEFIT AND TOLERABILITY OF ADJUVANT CHEMOTHERAPY IN ELDERLY STAGE III COLON

CANCER PATIENTS: A 3 YEAR RETROSPECTIVE AUDIT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S39

DIFFERING BIOLOGY OF BREAST CANCER ACCORDING TO AGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S40

COMORBIDITY AND CORRELATIONWITH ADJUVANT CHEMOTHERAPY OUTCOMES IN PATIENTS WITH

COLORECTAL CANCER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S40